Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference
Synergy Pharmaceuticals Inc., today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will present a corporate update at the Canaccord Genuity...
New upper extremity standard biopsy sites for diagnosis of small fiber neuropathy
Therapath LLC (www.Therapath.com),a leader in neuropathology laboratory services, has established normative values for two upper limb body sites that can now be used to...
Enrollment for Medicare IVIG Demonstration Project Begins August 8, 2014
The Immune Deficiency Foundation (IDF) is pleased to announce that the enrollment for the Medicare IVIG Demonstration Project will begin on August 08, 2014....
Neurocrine Biosciences Reports Second Quarter 2014 Results
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2014. For the second quarter of 2014, the...
Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its CE...
Cardiome to hold second quarter 2014 financial results conference call on August 11
Cardiome Pharma Corp. today announced that it will report financial results for the second quarter ended June 30, 2014 on the morning of Monday,...
AMRI ANNOUNCES SECOND QUARTER 2014 RESULTS
Total Revenue of $68.2 million, including Contract Revenue of $61.5 Million, up 15% Adjusted Diluted EPS of $0.22, up 100% Company Increases...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...